Length of hospital stay and 30-day readmission following heart failure hospitalization: Insights from the EVEREST trial

European Journal of Heart Failure

Volumn 17, Issue 10, 2015, Pages 1022-1031

  Khan, Hassan ^a   Greene, Stephen J ^b   Fonarow, Gregg C ^c   Kalogeropoulos, Andreas P ^a   Ambrosy, Andrew P ^d   Maggioni, Aldo P ^e   Zannad, Faiez ^f   Konstam, Marvin A ^g   Swedberg, Karl ^h   Yancy, Clyde W ^b   Gheorghiade, Mihai ^b   Butler, Javed ⁱ  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e ANMCO RESEARCH CENTER   (Italy)

^f Ctr Hospitalier Univ de Nancy   (France)

^g TUFTS MEDICAL CENTER   (United States)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

ⁱ STONY BROOK UNIVERSITY   (United States)

Author keywords

heart failure; hospital readmissions; length of stay

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINERALOCORTICOID ANTAGONIST; PLACEBO; TOLVAPTAN; VASOPRESSIN ANTAGONIST;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EASTERN EUROPE; FEMALE; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NORTH AMERICAN; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SOUTH AMERICA; TREATMENT RESPONSE; WESTERN EUROPE; AGED; CLINICAL TRIAL; COMORBIDITY; MIDDLE AGED; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICS AND NUMERICAL DATA;

AGED; COHORT STUDIES; COMORBIDITY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PATIENT READMISSION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84946471578     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.282     Document Type: Article

References (36)

1. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CS, Sato N, Shah AN, Gheorghiade M,. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol 2014; 63: 1123-1133.
2. Jencks SF, Williams MV, Coleman EA,. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009; 360: 1418-1428.
3. Greene SJ, Fonarow GC, Vaduganathan M, Khan SS, Butler J, Gheorghiade M,. The vulnerable phase after hospitalization for heart failure. Nat Rev Cardiol 2015; 12: 220-229.
4. American Hospital Association; Committee on Research. Bundled payment: AHA synthesis report. Health Research & Educational Trust 2010. http://www.aha.org/research/cor/content/BundledPayment.pdf (14 March 2015).
5. Moeller DJ, Evans J,. Episode-of-care payment creates clinical advantages. Manag Care 2010; 19: 42-45.
6. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC,. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008; 118: 1433-1441.
7. Desai AS, Stevenson LW,. Rehospitalization for heart failure: predict or prevent? Circulation 2012; 126: 501-506.
8. Kaboli PJ, Go JT, Hockenberry J, Glasgow JM, Johnson SR, Rosenthal GE, Jones MP, Vaughan-Sarrazin M,. Associations between reduced hospital length of stay and 30-day readmission rate and mortality: 14-year experience in 129 Veterans Affairs hospitals. Ann Int Med 2012; 157: 837-845.
9. Saczynski JS, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Yarzebski J, Goldberg RJ,. Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med 2010; 123: 1007-1015.
10. Vorhies JS, Wang Y, Herndon JH, Maloney WJ, Huddleston JI,. Decreased length of stay after TKA is not associated with increased readmission rates in a national Medicare sample. Clin Orthop Relat Res 2012; 470: 166-171.
11. Eapen ZJ, Reed SD, Li Y, Kociol RD, Armstrong PW, Starling RC, McMurray JJ, Massie BM, Swedberg K, Ezekowitz JA, Fonarow GC, Teerlink JR, Metra M, Whellan DJ, O'Connor CM, Califf RM, Hernandez AF,. Do countries or hospitals with longer hospital stays for acute heart failure have lower readmission rates?: Findings from ASCEND-HF. Circ Heart Fail 2013; 6: 727-732.
12. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C,. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 2007; 297: 1319-1331.
13. Gheorghiade M, Orlandi C, Burnett JC, Demets D, Grinfeld L, Maggioni A, Swedberg K, Udelson JE, Zannad F, Zimmer C, Konstam MA,. Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the Efficacy of Vasopressin antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST). J Card Fail 2005; 11: 260-269.
14. Blair JE, Zannad F, Konstam MA, Cook T, Traver B, Burnett JC Jr, Grinfeld L, Krasa H, Maggioni AP, Orlandi C, Swedberg K, Udelson JE, Zimmer C, Gheorghiade M,. Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program. J Am Coll Cardiol 2008; 52: 1640-1648.
15. O'Connor CM, Miller AB, Blair JE, Konstam MA, Wedge P, Bahit MC, Carson P, Haass M, Hauptman PJ, Metra M, Oren RM, Patten R, Pina I, Roth S, Sackner-Bernstein JD, Traver B, Cook T, Gheorghiade M,. Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program. Am Heart J 2010; 159: 841-849.
16. Krumholz HM, Lin Z, Keenan PS, Chen J, Ross JS, Drye EE, Bernheim SM, Wang Y, Bradley EH, Han LF, Normand SL,. Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA 2013; 309: 587-593.
17. Gorodeski EZ, Starling RC, Blackstone EH,. Are all readmissions bad readmissions? N Engl J Med 2010; 363: 297-298.
18. Thompson S, Kaptoge S, White I, Wood A, Perry P, Danesh J,. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. Int J Epidemiol 2010; 39: 1345-1359.
19. van Buuren S, Boshuizen HC, Knook DL,. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-694.
20. Ambler G, Omar RZ, Royston P,. A comparison of imputation techniques for handling missing predictor values in a risk model with a binary outcome. Stat Methods Med Res 2007; 16: 277-298.
21. Barnard J, Rubin D,. Small-sample degrees of freedom with multiple imputation. Biometrika 1999; 86: 948-955.
22. O'Connor CM, Starling RC, Hernandez AF, Armstrong PW, Dickstein K, Hasselblad V, Heizer GM, Komajda M, Massie BM, McMurray JJ, Nieminen MS, Reist CJ, Rouleau JL, Swedberg K, Adams KF, Jr., Anker SD, Atar D, Battler A, Botero R, Bohidar NR, Butler J, Clausell N, Corbalan R, Costanzo MR, Dahlstrom U, Deckelbaum LI, Diaz R, Dunlap ME, Ezekowitz JA, Feldman D, Felker GM, Fonarow GC, Gennevois D, Gottlieb SS, Hill JA, Hollander JE, Howlett JG, Hudson MP, Kociol RD, Krum H, Laucevicius A, Levy WC, Mendez GF, Metra M, Mittal S, Oh BH, Pereira NL, Ponikowski P, Tang WH, Tanomsup S, Teerlink JR, Triposkiadis F, Troughton RW, Voors AA, Whellan DJ, Zannad F, Califf RM,. Effect of nesiritide in patients with acute decompensated heart failure. N Engl J Med 2011; 365: 32-43.
23. Poole-Wilson PA,. Global differences in the outcome of heart failure: implications for clinical practice. J Am Coll Cardiol 2008; 52: 1649-1651.
24. Omenn GS, Conrad DA,. Implications of DRGs for clinicians. N Engl J Med 1984; 311: 1314-1317.
25. Rich MW, Freedland KE,. Effect of DRGs on three-month readmission rate of geriatric patients with congestive heart failure. Am J Public Health 1988; 78: 680-682.
26. Centers for Medicare and Medicaid Services HHS. Medicare program; hospital inpatient prospective payment systems for acute care hospitals and the long-term care hospital prospective payment system and fiscal year 2013 rates; hospitals' resident caps for graduate medical education payment purposes; quality reporting requirements for specific providers and for ambulatory surgical centers. final rule. Federal Register 2012; 77: 53257-53750.
27. Vaduganathan M, Bonow RO, Gheorghiade M,. Thirty-day readmissions: the clock is ticking. JAMA 2013; 309: 345-6.
28. Maggioni AP, Dahlstrom U, Filippatos G, Chioncel O, Crespo Leiro M, Drozdz J, Fruhwald F, Gullestad L, Logeart D, Fabbri G, Urso R, Metra M, Parissis J, Persson H, Ponikowski P, Rauchhaus M, Voors AA, Nielsen OW, Zannad F, Tavazzi L,. EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot). Eur J Heart Fail 2013; 15: 808-817.
29. Butler J, Fonarow GC, Gheorghiade M,. Need for increased awareness and evidence-based therapies for patients hospitalized for heart failure. JAMA 2013; 310: 2035-2036.
30. Desai AS,. Home monitoring heart failure care does not improve patient outcomes: looking beyond telephone-based disease management. Circulation 2012; 125: 828-836.
31. Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH,. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 2010; 303: 1716-1722.
32. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM,. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363: 2301-2309.
33. Feltner C, Jones CD, Cene CW, Zheng ZJ, Sueta CA, Coker-Schwimmer EJ, Arvanitis M, Lohr KN, Middleton JC, Jonas DE,. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Int Med 2014; 160: 774-784.
34. Mentz RJ, Schulte PJ, Fleg JL, Fiuzat M, Kraus WE, Pina IL, Keteyian SJ, Kitzman DW, Whellan DJ, Ellis SJ, O'Connor CM,. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION). Am Heart J 2013; 165: 193-199.
35. Bueno H, Ross JS, Wang Y, Chen J, Vidan MT, Normand SL, Curtis JP, Drye EE, Lichtman JH, Keenan PS, Kosiborod M, Krumholz HM,. Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010; 303: 2141-217.
36. Kociol RD, Liang L, Hernandez AF, Curtis LH, Heidenreich PA, Yancy CW, Fonarow GC, Peterson ED,. Are we targeting the right metric for heart failure? Comparison of hospital 30-day readmission rates and total episode of care inpatient days. Am Heart J 2013; 165: 987-994.